mRNA-LNP Reagents
mRNA-LNP (Messenger RNA-Lipid Nanoparticle) therapeutics involve encapsulating fragile mRNA strands within fatty, microscopic spheres. This delivery vehicle protects the mRNA from degradation and helps it cross cell membranes, allowing the body's own cells to manufacture specific proteins that treat or prevent diseases.
Lipid nanoparticles (LNPs) have emerged as significant candidates for mRNA delivery in immunotherapy, providing both protection to the mRNA and enhanced intracellular delivery efficiency. LIFESCT offers a list of key reagents and kits for mRNA-LNP vaccine reserach.

Modified Nucleoside-5′-Triphosphates
Base modified NTPs have been widely used for synthesis of modified mRNA to improve stability and reduce immunogenicity.
| Product Name | Cat. # | Price | View |
| N1-Methyl-UTP (10 µl) | M0154 | $99 | |
| Pseudo-UTP (10 µl) | M0155 | $99 | |
| 5-Methyl-CTP (10 µl) | M0156 | $99 |
Lipid Nanoparticles (LNPs)
Lipid nanoparticles (LNPs) are the most clinically advanced non-viral gene delivery system. Lipid nanoparticles safely and effectively deliver nucleic acids, overcoming a major barrier preventing the development and use of genetic medicines.
mRNA-LNP Related Products
